Cardiac Biotech Solutions

(OTC) CBSC

Current Price$0.04

Market Cap$6.57M

Since IPO (2015)-97%

5 Year-96%

1 Year+0%

1 Month+32%

Cardiac Biotech Solutions Financials at a Glance

Market Cap

$6.57M

Revenue (TTM)

$119.13K

Net Income (TTM)

$1.20M

EPS (TTM)

$-0.01

P/E Ratio

-3.75

Dividend

$0.00

Beta (Volatility)

0.02 (Low)

Dividend

$0.00

Beta (Volatility)

0.02 (Low)

Price

$0.04

Volume

39,267

Open

$0.04

Price

$0.04

Volume

39,267

Open

$0.04

Previous Close

$0.04

Daily Range

$0.03 - $0.04

52-Week Range

$0.02 - $0.08

Dividend

$0.00

Beta (Volatility)

0.02 (Low)

Price

$0.04

Volume

39,267

Open

$0.04

Previous Close

$0.04

Daily Range

$0.03 - $0.04

52-Week Range

$0.02 - $0.08

CBSC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cardiac Biotech Solutions

Industry

Pharmaceuticals

Sector

Health Care

CEO

Charles Martin

Website

www.cbscientificinc.com

Headquarters

Las Vegas, CA 92029, US

CBSC Financials

Key Financial Metrics (TTM)

Gross Margin

38%

Operating Margin

-11%

Net Income Margin

-10%

Return on Equity

Return on Capital

84%

Return on Assets

-3%

Earnings Yield

-26.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.57M

Shares Outstanding

165.44M

Volume

39.27K

Avg. Volume

19.65K

Financials (TTM)

Gross Profit

$41.40K

Operating Income

$1.33M

EBITDA

$1.69M

Operating Cash Flow

$1.25M

Capital Expenditure

$0.00

Free Cash Flow

$1.25M

Cash & ST Invst.

$50.01K

Total Debt

$263.09K

Cardiac Biotech Solutions Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2025YOY CHG

Revenue

$40.33K

+241.7%

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$6.57M

N/A

Market Cap/Employee

$1.31M

N/A

Employees

N/A

Net Income

$573.68K

+15.1%

EBITDA

$560.34K

-10.4%

Quarterly Fundamentals

Name

Q3 2025YOY CHG

Net Cash

$479.12K

-512.5%

Accounts Receivable

$88.37K

+888.9%

Inventory

$27.89K

+0.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$485.00K

+156.0%

Return on Assets

-3.19%

N/A

Return on Invested Capital

84.07%

N/A

Free Cash Flow

$182.25K

-13.0%

Operating Cash Flow

$182.25K

-13.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RMSLREMSleep Holdings, Inc.

RMSLREMSleep Holdings, Inc.$0.00+2.22%

ENZNEnzon Pharmaceuticals, Inc.

ENZNEnzon Pharmaceuticals, Inc.$6.38+0.00%

TGIFF1933 Industries Inc.

TGIFF1933 Industries Inc.$0.01+16.13%

CPIVFCaptiva Verde Wellness Corp.

CPIVFCaptiva Verde Wellness Corp.$0.01-57.14%

RSCFReflect Scientific, Inc.

RSCFReflect Scientific, Inc.$0.05+0.00%

TDSGFTelo Genomics Corp.

TDSGFTelo Genomics Corp.$0.04+0.00%

IDXGInterpace Biosciences, Inc.

IDXGInterpace Biosciences, Inc.$2.12+7.07%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

OWLBlue Owl Capital

OWLBlue Owl Capital$9.98+0.02%

Questions About CBSC

What is the current price of Cardiac Biotech Solutions?

Cardiac Biotech Solutions is trading at $0.04 per share.

What is the 52-week range for Cardiac Biotech Solutions?

Over the past 52 weeks, Cardiac Biotech Solutions has traded between $0.02 and $0.08.

How much debt does Cardiac Biotech Solutions have?

As of the most recent reporting period, Cardiac Biotech Solutions reported total debt of $485,000.

How much cash does Cardiac Biotech Solutions have on hand?

Cardiac Biotech Solutions reported $5,882 in cash and cash equivalents in its most recent financial results.

What is Cardiac Biotech Solutions’s dividend yield?

Cardiac Biotech Solutions does not currently have a dividend yield.

Cardiac Biotech Solutions

Cardiac Biotech Solutions Financials at a Glance

CBSC News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cardiac Biotech Solutions

CBSC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cardiac Biotech Solutions Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CBSC

What is the current price of Cardiac Biotech Solutions?

What is the 52-week range for Cardiac Biotech Solutions?

How much debt does Cardiac Biotech Solutions have?

How much cash does Cardiac Biotech Solutions have on hand?

What is Cardiac Biotech Solutions’s dividend yield?

Premium Investing Services